Diabetes, pollution and alcohol are biggest risk factors for dementia, study finds
By
John Roszkowski
Apr 01, 2024
Diabetes, air pollution and alcohol consumption were found to be top risk factors for dementia, according to a UK study.
Most US adults with type 2 diabetes meet criteria for GLP-RAs, SGLT2is
Feb 28, 2023
More than 82% US adults with type 2 diabetes meet the criteria to be prescribed the drugs, yet only 9% use either of them.
Diabetes is the No. 1 co-morbid condition linked to nursing home pressure ulcers, analysis finds
By
Tim Mullaney
Mar 03, 2014
Diabetes is the co-morbid condition most strongly associated with the development of pressure ulcers in nursing home residents, according to a new analysis of existing research.
FDA issues recall notice on Nova strips
By
Elizabeth Newman
Sep 01, 2013
Providers should monitor residents with diabetes to see if they are using recalled blood glucose test trips, the U.S. Food and Drug Administration has advised.
Study: Remote physiologic monitoring among Medicaid users skyrocketed from 2019 to 2021
By
Kristen Fischer
May 07, 2024
Between 2019 and 2021, remote physiologic monitoring via wearables and mobile apps soared by more than 1,300% among Medicaid users, a new study shows.
FDA approves first biosimilar insulin product
Jul 29, 2021
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine), provides cost-effective option
Amyloid buildup, small vessel disease tied to cognitive function in older adults with type 2 diabetes
By
Kristen Fischer
Feb 05, 2024
Scientists don’t have all the answers when it comes to understanding the link between diabetes and cognitive decline, especially when it comes to biomarkers for Alzheimer’s disease.
Care improvements reduce amputations
By
John O'Connor
Aug 01, 2013
Advances in diabetic foot ulcer treatments are helping reduce lower-extremity amputations, a new study finds. Researchers at the University of Iowa Department of Orthopaedics and Rehabilitation studied...
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Diabetes indicators improve with use of health incentives, CDC study finds
By
Alicia Lasek
Nov 10, 2022
Incentivizing patients to follow a lifestyle modification program helps them to improve a full range of diabetes-related health measures, according to a new meta-analysis.